Gattefossé has launched new offices and a state-of-the-art Technical Center of Excellence in Mumbai to support the growing market in India.

The facilities are designed to support innovation, encourage collaboration, and provide a productive work environment to help advance science. India is a global generic medicine producer and is one of the fastest-growing pharmaceutical sectors. 

This center brings together pharmaceutical and personal care application laboratories. The Technical Center of Excellence aims to support local customers and generate innovative applications for Gattefossé excipients based on an informed perception of Indian, regional, and global needs that would act as a valuable resource to the industry.

Laboratory projects are dedicated to advice customers on trouble shooting and provide ready-to-use guidelines for using Gattefossé excipients. For pharmaceuticals, this FDA accredited lab focuses on sustained release formulations, bioavailability enhancement and topical applications. 

"We recognize that India dominates the global market for generic and super generic drugs and serves as a major export hub for markets worldwide, including the US and Europe. With its strong scientific and technological foundation, and vast talent pool, India is perfectly positioned to partner with global companies. It is also establishing itself as a key player in manufacturing, R&D, and clinical trials. We are committed to empowering brands to meet the evolving needs of consumers, particularly across the thriving Asia-Pacific region,” said Eduardo De Purgly, Gattefossé Group CEO.